Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make an estimate of the average time between the (a) onset of symptoms and (b) formal diagnosis for patients with (i) lung, (ii) pancreatic, (iii) liver, (iv) brain, (v) oesophageal and (vi) stomach cancer.

The Department is supporting the National Health Service to meet the Faster Diagnosis Standard (FDS), for 75% of patients to be diagnosed or have cancer ruled out within 28 days of being referred urgently by their general practitioner (GP) for suspected cancer. NHS England collects and publishes monthly FDS performance data nationally and for individual cancer groups. Data is not available from the time of the onset of symptoms, but from referral.

To achieve the FDS, NHS England rolled out public awareness campaigns of cancer signs and symptoms, streamlined referral routes for different cancer types, and is increasing the availability of diagnostic capacity through the roll-out of more community diagnostic centres.

NHS England has also achieved full roll out of non-specific symptom pathways for patients who present with vague and non-site-specific symptoms which do not clearly align to a tumour type.

The NHS is also taking crucial steps to improve lung cancer outcomes for patients across England, including the roll out of the Lung Cancer Screening Programme, designed to identify cancer at an earlier stage, and which is aimed at high-risk individuals or people with a history of smoking between the ages of 55 and 74 years old.

Additionally, we set out expectations for renewed focus on cancer targets in the Elective Reform plan, published on 6 January 2025. We asked systems and providers to identify local opportunities in both community diagnostic centres and hospital based diagnostic services to improve performance against the FDS, to reduce the number of patients waiting too long for a confirmed diagnosis of cancer.

As part of developing the forthcoming National Cancer Plan for England, the Department has been working with members of the Less Survivable Cancers Taskforce to identify how to improve diagnosis, treatment, and outcomes for less survivable cancers, which includes lung, pancreatic, liver, brain, oesophageal, and stomach cancer.